From Clinical Thyroidology® for the Public: The FDA has warned against using the weight loss medications known as GLP-1RAs in patients with a personal or family history of medullary thyroid carcinoma (MTC) after animal studies indicated that these drugs could increase the growth of the cells that can develop into MTC. Papillary thyroid cancer arises from different thyroid cells than MTC. The aim of this study was to evaluate the impact of GLP-1RA exposure on cancer growth and progression in patients with low-risk papillary thyroid cancer undergoing active surveillance. Read More…
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.